Search Results - applications+%3e+soins+et+sant%c3%a9+%3e+traitement+%3e+pharmaceutique+%3e+syst%c3%a8me+nerveux+central

1 Results Sort By:
Novel Antisense Oligonucleotides Targeting RAPTOR Expression to Improve the Pathological Consequences of Genetic Mutations Causing mTORC1 Hyperactivity, including GATOR1 and TSC mutations.
NOVEL RNA INTERFERENCE AGENTS TARGETING mTORC1 ACTIVITY New hope for epilepsy and autism spectrum disorders (ASD) Shutterstock : 2203572829 UNMET NEED Epilepsy and Autism Spectrum Disosrder (ASD) are significant public health concerns, affecting over 65 million people worldwide for epilepsy and 1 in 100 children worldwide (1 in 36 children...
Published: 6/19/2025   |   Inventor(s): Antoine Desmeules, Paul Dutchak
Keywords(s): Innovation
Category(s): Objectifs de Développement Durable > ODD 03 : Bonne santé et bien-être, Sustainable Development Goals > Goal 03: Good Health and Well-Being, Secteurs > Sciences de la vie, Sectors > Life sciences, Applications > Soins et santé > Traitement > Pharmaceutique > Neurologie, Applications > Soins et santé > Traitement > Pharmaceutique > Système nerveux central, English Applications > Health and care > Treatment > Pharmaceuticals > Neurology, English Applications > Health and care > Treatment > Pharmaceuticals > Central nervous system